If you’ve been diagnosed with melanoma, the single most important thing you can do is move quickly through the staging process so your medical team can match treatment to how far the cancer has progressed. Melanoma caught early has an excellent prognosis, with five-year survival above 97% for Stage I disease. Even more advanced cases now have treatment options that didn’t exist a decade ago. Here’s what the path forward looks like.
Understanding Your Pathology Report
Everything that happens next depends on what your biopsy revealed. The most critical number on your pathology report is the Breslow thickness, a measurement in millimeters of how deep the melanoma has grown into the skin. This single number drives decisions about surgery, additional testing, and follow-up. The report also notes whether the surface of the tumor is ulcerated (broken through the top layer of skin), which bumps a melanoma into a higher risk category even if it’s thin.
Other details your pathologist records include the mitotic rate (how quickly the cancer cells are dividing), whether the surgical margins are clear, and whether there are microsatellites, which are tiny clusters of cancer cells near the primary tumor. If any of these terms are unclear in your report, ask your doctor to walk through each one with you. The specific questions worth asking: How thick is the melanoma? Has it ulcerated? Has it spread beyond the skin? These three answers shape your entire treatment plan.
How Melanoma Staging Works
Staging tells you how far the cancer has spread and what your likely outcomes are. Stage 0 means the melanoma is entirely in the top layer of skin. Stages I and II describe tumors that are still localized, with the distinction based on thickness and ulceration. Stage III means cancer has reached nearby lymph nodes. Stage IV means it has spread to distant organs.
The prognosis varies enormously across these stages. Stage I melanoma has a five-year survival rate of 97 to 99%. Stage III ranges widely, from 93% for the earliest substage (IIIA) down to 32% for the most advanced (IIID). Stage IV has historically carried a median survival of six to eight months, though newer treatments are improving those numbers significantly.
For tumors 0.8 mm thick or greater, or thinner tumors with ulceration or other high-risk features, your doctor will likely recommend a sentinel lymph node biopsy. This procedure identifies the first lymph node that drains the area around the tumor and checks it for cancer cells. The result determines whether you’re Stage I/II or Stage III, which completely changes the treatment approach.
Building the Right Medical Team
Melanoma treatment typically involves more than one specialist. A dermatologist or dermatopathologist confirms the diagnosis. A surgical oncologist or dermatology surgeon performs the excision and any lymph node procedures. If the cancer is advanced, a medical oncologist coordinates systemic treatments like immunotherapy or targeted therapy. Depending on the tumor’s location, you may also work with a head and neck surgeon or plastic surgeon for reconstruction.
For advanced or aggressive melanoma, getting care at a National Cancer Institute-designated comprehensive cancer center can make a real difference. These centers offer clinical trials and newly approved treatments that smaller facilities may not have access to. Even if you plan to receive treatment locally, a second opinion from one of these centers can confirm your staging and ensure you aren’t missing a better option. You don’t need a referral to contact most of them directly.
Surgery: The Primary Treatment
Surgery is the mainstay of melanoma treatment for all stages where the tumor can be removed. The procedure is called a wide local excision: the surgeon removes the melanoma site along with a margin of healthy skin around it to ensure no cancer cells remain at the edges.
The width of that margin depends on thickness. For melanomas 1 mm or thinner, the standard margin is 1 cm of surrounding skin. For tumors between 1 and 2 mm thick, margins range from 1 to 2 cm. For tumors thicker than 2 mm, the margin is 2 cm. These guidelines are consistent across virtually every international standard. The resulting wound is closed with stitches, and in areas where skin is tight (the face, hands, feet), a skin graft or flap may be needed.
If the sentinel lymph node biopsy comes back positive, your team will discuss whether to remove additional lymph nodes in that region or move to systemic therapy. This is one of the decisions where staging and your specific tumor biology matter most, and where a multidisciplinary tumor board review is especially valuable.
Immunotherapy and Targeted Therapy
For melanoma that has spread to lymph nodes or distant organs, or for high-risk tumors that could recur, systemic treatment has transformed outcomes over the past decade. There are two main categories.
Immunotherapy works by helping your own immune system recognize and attack cancer cells. The most common approach combines two drugs that block proteins cancer uses to hide from immune cells, essentially releasing the brakes on your T cells so they can fight the tumor. Another immunotherapy option works through a similar but slightly different immune checkpoint. These treatments are given by IV infusion, typically every few weeks, and can produce durable responses lasting years in some patients.
Targeted therapy is an option for roughly 40 to 50% of melanomas that carry a specific mutation in the BRAF gene. These oral medications block the faulty signaling pathway that drives cancer growth. They often shrink tumors very quickly, though the response when used alone tends to last about a year. Combining a BRAF-blocking drug with a second drug that targets a related protein called MEK extends the benefit considerably. Your tumor will be tested for this mutation as part of your workup.
Both categories of treatment carry side effects, some of them serious, but your oncologist will monitor you closely and adjust as needed. The choice between immunotherapy and targeted therapy (or a combination) depends on your mutation status, how fast the cancer is growing, and your overall health.
Clinical Trials Worth Considering
Melanoma is one of the most actively researched cancers, and many of today’s standard treatments started as clinical trials just a few years ago. Trials are available for nearly every stage, from high-risk early melanoma to metastatic disease. They may offer access to newer drug combinations, novel immune-based approaches, or vaccines designed to prevent recurrence.
ClinicalTrials.gov is a searchable public database where you can filter by cancer type, stage, and location. Your oncologist can also identify trials you may qualify for. Enrolling in a trial doesn’t mean you’ll receive an unproven treatment instead of standard care. Many trials compare a new approach against the current best option, so participants often receive at least the standard of care.
Your Follow-Up Schedule
After treatment, regular monitoring is essential because melanoma can recur years later, and people who’ve had one melanoma are at higher risk of developing a second one. The schedule depends on your stage at diagnosis.
For Stage 0 (melanoma in situ), you’ll need a full skin exam once a year for life, with no routine imaging. For Stages IA through IIA, expect exams every 3 to 12 months for five years, then annually. Routine imaging scans aren’t typically recommended at these stages. For Stages IIB through IV, the schedule is more intensive: exams every 3 to 6 months for the first two years, every 3 to 12 months for the next three years, and at least annually after that. Imaging such as CT scans, PET scans, or brain MRIs may be ordered every 3 to 12 months for up to five years.
Between appointments, do your own skin checks monthly. Look for new moles, changes in existing ones, or any unusual spots near your surgical scar. Catching a recurrence or new melanoma early makes a significant difference in outcome.
Emotional and Financial Support
A melanoma diagnosis is stressful, and the anxiety doesn’t end when treatment does. Several organizations offer free support specifically for cancer patients. CancerCare provides professional counseling and help navigating financial challenges. Cancer Hope Network connects you one-on-one with someone who has been through a similar diagnosis. The Cancer Support Community offers group programs both in person and online. For young adults dealing with the financial fallout of treatment, The Samfund provides grants and financial planning resources. The AIM at Melanoma Foundation maintains a comprehensive directory of these organizations along with educational materials to help you understand your options at every stage.